Actinobac Biomed's Seed VC - III Round

Actinobac Biomed raised a round of funding on July 12, 2017. Investors include Kairos Ventures.

Actinobac Biomed is a biopharmaceutical company developing therapeutics for multiple indications, including blood cancers, autoimmune/inflammatory diseases, and HIV. Its drug candidates are based upon…

Articles about Actinobac Biomed's Seed VC - III Round: